Poorva Bindal to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Poorva Bindal has written about Antineoplastic Agents, Immunological.
Connection Strength
0.909
-
Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511.
Score: 0.583
-
Sehgal K, Gill RR, Widick P, Bindal P, McDonald DC, Shea M, Rangachari D, Costa DB. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Netw Open. 2021 02 01; 4(2):e2037120.
Score: 0.173
-
Mathew Thomas V, Bindal P, Ann Alexander S, McDonald K. Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. J Oncol Pharm Pract. 2020 Mar; 26(2):459-461.
Score: 0.152